Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Assets Average (2024 - 2025)

Historic Assets Average for Inhibrx Biosciences (INBX) over the last 2 years, with Q3 2025 value amounting to $194.8 million.

  • Inhibrx Biosciences' Assets Average fell 1900.1% to $194.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.8 million, marking a year-over-year decrease of 1900.1%. This contributed to the annual value of $244.3 million for FY2024, which is N/A changed from last year.
  • Per Inhibrx Biosciences' latest filing, its Assets Average stood at $194.8 million for Q3 2025, which was down 1900.1% from $227.4 million recorded in Q2 2025.
  • Inhibrx Biosciences' 5-year Assets Average high stood at $240.5 million for Q3 2024, and its period low was $194.8 million during Q3 2025.